Latest filing published 19 Aug 2024 for Xtant Medical Holdings, Inc., €31k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Kevin D. Brandt in Xtant Medical Holdings, Inc., where the filings describe the role as senior executive. We count 7 filings; the first trade dates from 9 July 2021 and the latest from 15 August 2024.
The open-market record is one-sided, with 1 purchase worth €46k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 6 share grants.
The latest filing, published on 19 August 2024, reports a share grant of €31k in Xtant Medical Holdings, Inc. The last purchase on record was published on 17 November 2023, which is 1,066 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations